eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2021
vol. 38
 
Share:
Send email
Share:
abstract:
Original paper

Intervention in anaphylaxis: the experience of one paediatric centre based on NORA reports

Izabela Tarczoń
1
,
Urszula Jedynak-Wąsowicz
2
,
Grzegorz Lis
2
,
Tomasz Tomasik
2
,
Piotr Brzyski
3
,
Ewa Cichocka-Jarosz
2

  1. “Przyladek Zdrowia”, Krakow, Poland
  2. Department of Paediatrics, Jagiellonian University Medical College, Krakow, Poland
  3. “Dziupla” Statistical Analysis, Krakow, Poland
Adv Dermatol Allergol 2021; XXXVIII (2): 235-243
DOI: https://doi.org/10.5114/ada.2019.89715
Online publish date: 2020/02/19
View full text Get citation
 
Introduction
Intramuscular adrenaline administration is the primary intervention in anaphylaxis.

Aim
To analyse the data on intervention in children admitted due to anaphylaxis to the tertiary paediatric centre and compare them to the data from the Network for Online-Registration of Anaphylaxis.

Material and methods
A validated structured on-line questionnaire was used to collect data concerning the first and second-line intervention in anaphylaxis. The study was conducted in cooperation with the European Anaphylaxis Registry.

Results
The study group comprised 114 children (76 boys, 66.87%) aged 5 months–17 years with the predominance of moderate-to-severe anaphylaxis (grade III in Ring and Messmer’s, and grade IV in Mueller’s scale). In 103 (90.4%) children the first line of medical intervention was provided by medical staff. In the first-line intervention 39 (34.8%) children were given adrenaline. Five (4.4%) children were given the second dose of adrenaline and were admitted to the intensive care unit. In the second-line intervention adrenaline was given to 12 (15.6%) children. In one third it was at least the second reaction to the same trigger. Children treated with adrenaline were older (9.3 ±4.8 years), in comparison to those not treated (7.3 ±4.6 years, p = 0.034). Directly after the episode of anaphylaxis the children got the prescription for the adrenaline autoinjector in 35.1%, emergency training in 7.9%, and counselling on the avoidance of the anaphylaxis trigger in 30.7%. Grade III R&M reaction increased 3-fold the odds of AAI prescription (95% CI: 1.08–8.15).

Conclusions
There is a strong need to continue education on proper management of anaphylaxis in children.

keywords:

anaphylaxis, medical intervention, adrenaline, register, children
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.